Study of an injected medicine in healthy volunteers
Part of Hormones & metabolism clinical trials.
This study tests a new injected medicine called SYH2092 in healthy adults. It aims to see how safe it is and how the body handles it, which could help develop a future treatment for conditions like diabetes or obesity.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 60 years old.
- Your weight must be at least 50 kg (about 110 lbs) with a body mass index (BMI) between 18 and 35.
- You should be generally healthy, with no major medical conditions like heart disease, diabetes, or serious stomach problems.
- You cannot have taken certain medications or supplements recently, and you should be able to avoid alcohol, smoking, and heavy exercise during the study.
- If you are able to have children, you must agree to use effective birth control and not plan a pregnancy for 6 months after the last dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new injection called SYH2082 in healthy volunteers to see how the body handles it and what side effects might occur. It is an early-stage trial that may help in developing a treatment for weight-related conditions.
This study tests an investigational injection called SYH2069 for weight loss in people who are obese but do not have diabetes. It aims to see if the drug is safe and helps reduce body weight.
This study tests a new medication called SYH9017 for people who are overweight or have obesity. It aims to see how safe the drug is, how well it is tolerated, and how the body processes it. Participants will receive either the drug or a placebo and be monitored closely.
This study tests a new injected medicine (called HS-20136-2) to see if it is safe and how the body handles it. It is an early (phase 1) trial that includes healthy people and people with overweight, and the goal is to learn about possible effects on weight and metabolism.
This study tests a new injection called SYH2070 for people with high triglycerides and high LDL cholesterol. The goal is to see if a single dose is safe and how the body processes the medication. It is for people who have not been on cholesterol-lowering drugs recently.
This trial tests a new injection called SHR-2906, first in healthy people to check safety, then in people with obesity to see how well it works. It may help with weight management.
Hear when a new Overweight or Obesity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.